Innovations in Obesity Drugs and Market Potential

This chapter explores groundbreaking advancements in oral medications for diabetes and obesity, presenting them as viable alternatives to injectables. The discussion touches on the benefits of these small molecule drugs and speculates on their impact on market growth and associated economic factors.